英卡思学院

注册新账号

介绍
大会日程
讲者
赞助企业名单
大会地图
认证

回到上页

学院
大会日程

针对您所在时区的直播课程/会议的时间

时区参照: (UTC-04:00) America, New York

时区

时区:改换时区

If you are logged in, change your default time zone in your account

Naked truth about exosomes and its implications in aesthetic medicine today - (ExoCoBio Inc. symposium)

聚焦大会日程

会议室： Webinar
日期： 2021年 7月 6日星期二从 11:00 至 12:30
组织形式： 企业卫星会 > 参展公司进行的促销和教育会议

本场演讲内容

小时	讲者	演讲标题	讲稿摘要	数字
11:00	Steven R COHEN 医师	Facial regenerative medicine and potential role of exosome in aesthetic medicine	查看	111846
11:15	Tunc TIRYAKI 医师	Research & clinical data on exosomes in aesthetic surgery: update		111847
11:30	Diane Irvine DUNCAN 医师	Application of lyophilized exosomes (derived from adipose stem cell) in aesthetic medicine		111848
11:45	Inigo DE FELIPE Y GARATE 医师	Exosomes in treatment of Androgenetic Alopecia (AGA)	查看	111849
12:00		Q&A		111850

进入前一天 (Webinar)

进入后一天 (Webinar)

Steven R COHEN 医师

整形外科医师

美国

其他作者 :

Facial regenerative medicine and potential role of exosome in aesthetic medicine

Objectives: 1. Present a brief history of regenerative medicine
2. Introduce a concept of dynamic facial age management
3. Discuss Nanofat, Stromal Vascular Fraction and introduce Exosomes

Introduction: Regenerative medicine was kickstarted in the early 2000's with the findings of stem cells and regenerative cells in fat. The promise of regenerative medicine has been to utilize the body's own repair mechanisms and the cells involved as therapies for numerous types of injuries and acquired disorders. Herein, I will outline a brief history of adipose derived stem and regenerative cells, the development of a proven technique of regenerative facial fat grafting and introduce the use of exosomes, which may turn out to be the most powerful biologic we have available to date.

Materials / method: The history of regenerative medicine will be briefly covered and an example of how regenerative medicine and exosomes can be applied in facial aesthetics will be discussed.

Results: Current prospective data on outcomes combining regenerative strategies with lasers and surgery will be presented as case examples of regenerative facial surgery.

Conclusion: New concepts in regenerative medicine have progressed to standardized treatment regimens that can be used as a template for new advances. Exosome therapies may ultimately represent the future of the regenerative medical field.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
是
请注明名称（个人，公司，学会等等）: ExCoBio- honorarium for this presentation

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: The Mage Group, UK (nanocube); MMT

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
是
请注明日期: pending
和审阅情况: Patent on ITR2 anatomic and regenerative fat grafting

这项工作的完成感谢以下机构的支持： ExCoBio

Tunc TIRYAKI 医师

美容整型外科医师

土耳其

其他作者 :

Research & clinical data on exosomes in aesthetic surgery: update

Diane Irvine DUNCAN 医师

整形外科医师

美国

其他作者 :

Application of lyophilized exosomes (derived from adipose stem cell) in aesthetic medicine

Inigo DE FELIPE Y GARATE 医师

皮肤科医师

西班牙

其他作者 : De Vargas Machuca A, Lopez Sanchez C

Exosomes in treatment of Androgenetic Alopecia (AGA)

Objectives: We designed a randomized double-blind controlled study to assess the effects of Growth Factors contained in ASC-Exosomes added to conventional AGA treatment.

Introduction: Platelet Rich Plasma (PRP) has been used as a Growth Factors (GF) source in Androgenetic Alopecia (AGA). New sources of GF contained in stem cell-derived exosomes, and their role in AGA is still to be determined.

Materials / method: Methods:
80 male patients were diagnosed with AGA and received standard treatment with a daily intake of 5 mg Oral Minoxidil (OM), 0.5 mg Oral Dutasteride (OD), and 299 mg oral Saw Palmetto (SP). 40 were then randomly assigned to the ASC-Exosome group (EXO) and received additionally 6 sessions of scalp infiltrations per month with exosomes containing GF. The other 40 were randomly assigned to the Control group (sham or C) and received instead 6 sessions of saline solution infiltrations. Macroscopic pictures were taken at baseline and 12 months after treatment. Through trichoscopy pictures,

Results: All patients finished the treatment. At the 6 and 12 months evaluation, hair density in group C had overall increased by 14.4% and 16.7%, whereas patients in the EXO group had a hair density increase of 22.6% and 25.4% respectively. Terminal hairs increased 18% and 25% at 6 and 12 months respectively in the Control group and 27% and 36% respectively in the ASC-Exosome group.

Conclusion: Growth Factors and other Bioactive ingredients contained in ASC-Exosomes increase the density of hair in AGA with safety and should be considered as an adjuvant to conventional therapy with OD, OM, and SP in AGA.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
是
请注明名称（个人，公司，学会等等）: Exocobio

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Q&A

您有问题要问？

在我们的常见问题解答中快速找到答案

大会

英卡思亚洲年会
英卡思中国大会
英卡思巴黎国际年会
英卡思美洲年会
英卡思亚洲年会

关于我们

公司
隐私政策
法律信息

学院

主页
课程
Webinars
探索
博客

支援

教育援助

保持联系

联系我们

登录名/电邮地址

密码

保持登录状态

密码遗失 ? 还没有账号？现在注册

保持登录状态

academy.Do_not_have_an_account_yet 现在注册

学院 大会日程

Naked truth about exosomes and its implications in aesthetic medicine today - (*ExoCoBio Inc. symposium*)

本场演讲内容

学院
大会日程

Naked truth about exosomes and its implications in aesthetic medicine today - (ExoCoBio Inc. symposium)

本场演讲内容